Patents by Inventor Clara Singer

Clara Singer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers associated with the therapeutic efficacy of glatiramer acetate
    Publication number: 20100285600
    Abstract: The present invention is directed to methods and kits based, at least in part, on the identification of allele-specific responsiveness or non-responsiveness to glatiramer acetate for the treatment of autoimmune disorders, such as relapsing-remitting multiple sclerosis. The allele-specific responsiveness or non-responsiveness is based on polymorphisms in the following genes, CTSS, MBP, TCRB, CD95, CD86, IL-1R1, CD80, SCYA5, MMP9, MOG, SPP1 and IL-12RB2.
    Type: Application
    Filed: February 22, 2010
    Publication date: November 11, 2010
    Inventors: Doron Lancet, Jacques Beckmann, Nili Avidan, Edna Ben-Asher, Clara Singer, Liat Hayardeny, Dan Goldstaub, Iris Grossman, Ariel Miller
  • Markers associated with the therapeutic efficacy of glatiramer acetate
    Publication number: 20060240463
    Abstract: The present invention is directed to methods and kits based, at least in part, on the identification of allele-specific responsiveness or non-responsiveness to glatiramer acetate for the treatment of immune disorders, such as relapsing-remitting multiple sclerosis. The allele-specific responsiveness or non-responsiveness is based on polymorphisms in the following genes, CTSS, MBP, TCRB, CD95, CD86, IL-1R1, CD80, SCYA5, MMP9, MOG, SPP1 and IL-12RB2.
    Type: Application
    Filed: April 24, 2006
    Publication date: October 26, 2006
    Inventors: Doron Lancet, Jacques Beckmann, Nili Avidan, Edna Ben-Asher, Dan Goldstaub, Liat Hayardeny, Iris Grossman, Ariel Miller, Clara Singer